Mild fear- or aggression-related sedation (FAS) may be controlled by which approach?

• A. one drug class
• B. generally alpha-2 agonist
• C. multimodal protocols
• D. more potent drugs

Answer: (A)

Mild fear- or aggression-related sedation is best managed with multimodal protocols that combine several strategies to reduce fear and promote cooperation. Fear responses involve multiple pathways and can vary between animals, so relying on a single drug class often fails to fully blunt anxiety without risking side effects or inadequate control. A multimodal approach brings together different mechanisms of action—often using a low-dose anxiolytic or sedative alongside other agents that support analgesia, anxiolysis, or mild sedation—while also incorporating nonpharmacologic strategies such as calm environmental management, gentle handling, and familiarization. This combination allows lower doses of each drug, reducing the risk of oversedation or adverse effects and increasing predictability and welfare during procedures. While alpha-2 agonists are commonly used components, they are most effective when integrated into a broader, multimodal plan rather than relied on alone. Conversely, simply using more potent drugs increases the likelihood of oversedation, respiratory depression, and delayed recovery, which is not ideal for mild FAS management.